European CVMP Adopts Vet Drug MRL Opinion on Bambermycin
On April 23, Europe's Committee for Medicinal Products for Veterinary Use (CVMP) published an adopted opinion recommending that no MRL is required for bambermycin in rabbit.
Based on the CVMP opinion, the European Commission will adopt a legally binding Regulation establishing the MRLs for the substance. Applicants may request re-examination of any CVMP opinion within 15 days of its publication.
The proposed exemption from an MRL from the summary opinion will display in the BCGloabl Veterinary Drug MRL Database on April 24, 2019.